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Molecular genetic abnormalitiesA miscarriage is the most frequent complication of a pregnancy. Poor chromosome preparations, culture failure,
or maternal cell contamination may hamper conventional karyotyping. Techniques such as chromosomal
comparative genomic hybridization (chromosomal‐CGH), array-comparative genomic hybridization (array-CGH),
ﬂuorescence in situ hybridization (FISH), multiplex ligation-dependent probe ampliﬁcation (MLPA) and quantita-
tiveﬂuorescent polymerase chain reaction (QF-PCR) enable us to trace submicroscopic abnormalities.We found the
prevalence of chromosome abnormalities in women facing a single sporadic miscarriage to be 45% (95% CI: 38–52;
13 studies, 7012 samples). The prevalence of chromosome abnormalities in women experiencing a subsequent
miscarriage after preceding recurrent miscarriage proved to be comparable: 39% (95% CI: 29–50; 6 studies 1359
samples). More chromosome abnormalities are detected by conventional karyotyping compared to FISH or
MLPA only (chromosome region speciﬁc techniques), and the same amount of abnormalities compared to
QF-PCR (chromosome region speciﬁc techniques) and chromosomal‐CGH and array-CGH (whole genome
techniques) only. Molecular techniques could play a role as an additional technique when culture failure or
maternal contamination occurs: recent studies show that by using array-CGH, an additional 5% of submicroscopic
chromosome variants can be detected. Because of the small sample size as well as the unknown clinical
relevance of these molecular aberrations, more and larger studies should be performed of submicroscopic
chromosome abnormalities among sporadic miscarriage samples. For recurrent miscarriage samples molecular
technique studies are relatively new. It has often been suggested that miscarriages are due to chromosomal
abnormalities in more than 50%, but the present review has determined that chromosomal and submicroscopic
genetic abnormalities on average are prevalent in maximally half of the miscarriage samples. This article is part
of a Special Issue entitled: Molecular Genetics of Human Reproductive Failure.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Miscarriage is the spontaneous loss of a clinically established
intra-uterine pregnancy before the fetus has reached viability. It
includes pregnancy losses until the maximum of 24 weeks of gestation
[1]. It is themost frequent complication of a pregnancy. Between 10 and
15% of all clinically recognized pregnancies result in a spontaneous
miscarriage. The overall prevalence of pregnancy losses, including
biochemical pregnancies is generally assumed to be 4–5 times higher
[1]. Around a quarter of all women experience at least one miscarriage
during their lives [2,3].
Up to 5% of all couples will face recurrent miscarriage. The deﬁnition
may vary but starts when at least two or more miscarriages have
occurred [4,5]. The sequence of the miscarriages does not necessarilyolecular Genetics of Human
ve Medicine, Department of
ntre, University of Amsterdam,
J. van den Berg).
rights reserved.have to be consecutive [5]. Half of the ﬁrst-trimester miscarriages are
caused by fetal chromosome abnormalities diagnosed by conventional
techniques [6].
Techniques such as Chromosomal Comparative Genomic Hybridiza-
tion (CGH), array–Comparative Genomic Hybridization (array-CGH),
Fluorescence in situ hybridization (FISH), Multiplex Ligation-dependent
Probe Ampliﬁcation (MLPA) and Quantitative Fluorescent Polymerase
Chain reaction (QF-PCR) have overcome some disadvantages inherent
to conventional cytogenetic techniques, including poor chromosome
preparations, culture failure, or maternal cell contamination. These tech-
niques have identiﬁed more abnormalities in early miscarriages [7–9].
Until now little is known about the contribution of the newer techniques
to resolving the clinical problem.
Searching PubMed, Medline and EMBASE until October 2011 iden-
tiﬁed relevant studies. Search criteria used were related to the preva-
lence of cytogenetic abnormalities or submicroscopic abnormalities
in relation to sporadic miscarriage and recurrent miscarriage. Esti-
mates of 95% conﬁdence intervals (CI) were determined for preva-
lence of chromosome abnormalities as well as for actual proportions
of abnormalities as measured by the karyotyping, array-CGH, FISH,
MLPA and/or QF-PCR. Pooled estimates were calculated based on
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meta-analyses in STATA 11.2.
In this review we present what is currently known about the preva-
lence and actual proportions of cytogenetic and submicroscopic abnor-
malities in sporadic aswell as recurrentmiscarriage.Wewill discuss the
clinical ﬁndings that have come to light by using molecular techniques
by paying attention to the capability of speciﬁc tests.
2. Current knowledge
Half of the sporadic early miscarriages (b12 weeks gestational age)
are caused by fetal chromosome abnormalities, and nearly a third in
second trimester miscarriages as was reported by a former review
[6]. Cytogenetic studies have shown that most of these abnormalities
are numerical chromosome abnormalities (86%), and a minority of
the cases is caused by structural chromosome abnormalities (6%) and
chromosome mosaicism (8%) [6].
It is hypothesized that the majority of chromosome abnormali-
ties detected in spontaneous miscarriages occurs de novo and results
from random errors produced during gametogenesis and embryonic
development [10]. The risk of a fetal trisomy raises with increasing
maternal age [11]. Since the average age of women bearing their ﬁrst
child has increased strongly over the last two decades in western coun-
tries, it is likely that fetal trisomy will become more frequent [12].
In women with recurrent miscarriage, chromosome abnormalities
are prevalent as well, but the scale of the problem is less clear. One
study showed that fetal aneuploidy contributes to recurrentmiscarriage
in a small proportion of the patients [13]. While others showed aneu-
ploidy in larger number of patients [2,14–16].
The majority of miscarriages occur in chromosomally normal
parents. Balanced chromosome abnormalities are present in about 2–5%
of patients with recurrent miscarriage [4].
2.1. Conventional techniques
Conventional karyotyping is deﬁned as the morphological charac-
terization of the chromosomal complement of an individual including
number, form and size of the chromosomes. It can detect abnormalities
throughout the entire genome and is therefore used as the standard for
detecting chromosome abnormalities in miscarriages samples (Table 1).
2.1.1. Cytogenetic abnormalities and sporadic miscarriage
A review of the literature in 2000 reported that 49% of the sporadic
miscarriage samples that had been karyotyped, showed chromosome
abnormalities. The spectrum of these chromosome abnormalities in-
cluded 86% numerical abnormalities, 6% structural abnormalities and
8% other chromosome abnormalities like mosaicism, or double and
triple trisomies [6]. Table 2 provides a new overview of reported chro-
mosome abnormalities since the 2000 review, found after karyotyping
in a large sporadic miscarriage sample population [7–9,13,17–25]. The
pooled prevalence in 7012 samples tested of a chromosome abnormal-
ity from 2000 to 2011 was 45% (95% CI: 38–52). This prevalence of
chromosome abnormalities is comparable to the 49% found in the pre-
vious review (45% after 2000 versus 49% before 2000) [6]. The propor-
tions of chromosome abnormalities across the different studies ranges
from 23 to 61% and one study alone represents 5555 samples collected
for karyotyping being 81% of all samples tested amongst studies, as
shown by Table 2 [25]. The overall failure rate was 21% (95% CI:
13–30). To avoid overrepresentation of this large study, pooled esti-
mates were calculated based on weighted averages of the individual
studies using random-effects meta-analyses.
Subdivision into type of chromosome abnormalities remained
comparable to the 2000 review: numerical abnormalities (91%)
followed by structural abnormalities (6%) and others (6%), but the
age related percentage of trisomies (63%) was increased compared
to the 2000 review (52%). The last group included mosaicism, double,triple and quadruple trisomies, autosomal monosomy and one triso-
my plus a balanced translocation.2.1.2. Cytogenetic abnormalities and recurrent miscarriage
Seven studies investigated cytogenetic abnormalities in mis-
carriage samples of women with preceding recurrent miscarriage
[2,13–17,26–28]. One study estimated the rate of chromosome abnor-
malities in recurrent miscarriage samples among women with three
miscarriages only over the age of 35 [27]. Because of this age selection
criterion we did not include this study in the summarized table. Six
studies could be summarized, see Table 3, with an overall failure
rate of 25% (95% CI: 9–41) [2,13–17,26–28]. Less than half of the
total number of 1359 successful karyotyped miscarriage samples
showed an abnormal karyotype (39%; 95% CI: 29–50). The spectrum
of chromosome abnormalities included 90% numerical abnormalities,
3% structural abnormalities and 13% other chromosome abnormalities.
It shows that remarkably high numbers of chromosome abnormalities
occur in miscarriage samples of women with recurrent miscarriage.
Two studies deﬁned recurrent miscarriage as two or more miscarriages
[13,14]. While two other studies used three or more miscarriages in
their deﬁnition [3,15]. The last two studies did not mention the deﬁni-
tion of recurrent miscarriages at all [2,26]. The pooled prevalence of
chromosome abnormalities in miscarriage samples of women with
recurrent miscarriage, although tested in a smaller amount of samples
(39%, 95% CI: 29–50) proved to be comparable with the pooled preva-
lence of chromosome abnormalities in miscarriage samples of women
facing a single sporadic miscarriage (45%, 95% CI: 38–52).2.2. Submicroscopic genetic abnormalities and sporadic miscarriage
A part of the miscarriages may be due to submicroscopic chromo-
somal changes [28]. The introduction of array-CGH enabled us clinicians
to search for submicroscopic ‘miscarriage genes’. These submicroscopic
chromosomal changes are also deﬁned as DNA copy number variants
(CNVs). The pathogenicity of a CNV can be made plausible by de novo
origin, larger size and the presence of genes that have been associated
with disease [29].
Seven studies investigated the use of array-CGH for detecting
submicroscopic genetic abnormalities in sporadic miscarriage samples
[7–9,20,30–32]. Table 4 provides an overviewof the reported submicro-
scopic abnormalities among these studies, entailing 362miscarriages in
total [7–9,20,30–32]. These combined studies suggest that in 5% of all
sporadicmiscarriages CNVs are foundwhich cannot be detected by con-
ventional cytogenetic analysis. One study included both patients with
sporadic and recurrent miscarriages [33]. Eight of the 25 included pa-
tients suffered from recurrent miscarriage. Four submicroscopic chro-
mosome abnormalities were found by two different arrays (Xp22.31,
12q33.3, 5p15.33 and Xp22.31). Additionally, parents were examined
to check the parental origin. The four submicroscopic chromosome
abnormalities were not presented before in the databases of benign
copy number changes [33].
However the clinical relevance of these CNVs remains unclear.
Still, only a relatively low number of samples have been tested in
this area of research so far. Only one study examined the parents
additionally, to determine whether the changes were inherited or
de novo, as such testing is of clinical value [32]. This small study iden-
tiﬁed six unique copy number variants (CNVs), formerly not reported,
in 5 of the 17 embryos (19% of all cases). All six were b250 kb in size.
On the basis of parental array-CGH analysis, only in one embryo a de
novo origin of a CNV was determined (at 13q32.1). The number of
cases reported is small and it is precisely for that reason that further
studies are recommended to determine the size of distribution of
de novo CNVs in this clinical group and whether these CNVs contribute
to the cause of the miscarriage.
Table 1
Established advantages and disadvantages of techniques used for genetic testing of miscarriage samples.
Advantages Disadvantages
Whole genome techniques
Karyotyping • Gold standard • Limited resolution (>3–5 Mb)
• Abnormalities detected throughout the entire
genome
• Microdeletion/duplication syndromes not
detectable
• High speciﬁcity • Origin of small supernumerary marker
chromosomes not detectable
• Subtle rearrangements of subtelomeric regions
undetected
• Chance of culture failure or maternal
contamination
• Time intensive (10–21 days)
• Laborious procedure
• High costs
Chromosomal comparative
genomic hybridization (CGH)
• Resolution is limited to metaphase chromosomes
(5–10 Mb pairs).
• Ploidy status not detectable
• Abnormalities detected throughout the entire
genome
• Balanced rearrangements not detectable
• Detection of deletions, duplications, or
ampliﬁcations
• High costs (most expensive procedure)
• Archival formalin ﬁxed and parafﬁn embedded
placenta or fetal
tissues can be investigated
• Laborious procedure
• Quick results (5 days) • Chance of false positives test results including lack
of useable DNA products
Array-comparative genomic
hybridization (array-CGH)
• Resolution ranging from oligonucleotides
(25–80 bp) to bacterial
artiﬁcial chromosomes (BACs) (80–200 kb)
• Ploidy status not detectable
• Abnormalities detected throughout the entire
genome,
• Balanced rearrangements not detectable
• Detection of deletions, duplications, or
ampliﬁcations (including submicroscopic
imbalances)
• High costs (most expensive procedure)
• Archival formalin ﬁxed and parafﬁn embedded
placenta or fetal
tissues can be investigated
• Chance of false positives test results including lack
of useable
DNA products
• Quick results (5 days)
Chromosome speciﬁc techniques
Fluorescence in situ hybridization (FISH) • Polyploidy, monosomies and trisomies are
detected
• Abnormalities distinct from the genomic
segments for which probes have been
designed cannot be detected.
• Performed directly on interphase cells and
eliminates the
requirement for cell culture
• Structural chromosome abnormalities not
detectable
• Quick results (1–2 days) • Chance of false positives test results including lack
of useable DNA products
Multiplex ligation-dependent probe ampliﬁcation
(MLPA)
• Targets a large number of small DNA sequences
(50–70 nt)
• Mosaicism, polyploidy and balanced chromosome
rearrangements not detectable
• Quick results (1–3 days) • Maternal contamination not detectable
• Low costs • Chance of false positives test results including lack
of useable DNA products
Quantitative ﬂuorescence polymerase
chain reaction (QF-PCR)
• Quick results (3–4 days) • Provides only information on the limited number
of chromosomes the test is
designed for, usually chromosome 13, 18, 21 and
sex chromosomes
• Detection of maternal contamination • Chance of false positives test results including lack
of useable DNA products
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Idiopathic recurrent miscarriage presents a large problem for
patient and clinician. Despite extensive evaluation, in many cases no
underlying explanation for the recurrence of miscarriages can be
found [3]. So there is a possibility that submicroscopic chromosomal
changes, not detectable by conventional cytogenetic analysis, can
account for some part of these miscarriages. Theoretically a parental
CNV could contribute to the pregnancy loss if a gene is, or genes
are, disrupted involving early development of the embryo, but this
seems to be an unlikely cause of recurrent miscarriage.
One recent small study investigated 27 miscarriages samples and 22
partners from 20 couples with idiopathic recurrent miscarriage [29]. In
13 miscarriages samples of 8 couples with recurrent miscarriage, 11unique CNVs could be identiﬁed. All CNVs identiﬁed have not previously
be described, proved to be inherited and are therefore not likely to be of
clinical value. Furthermore, this study has a small sample size [29].
2.4. Accuracy of the whole genome techniques
Conventional karyotyping is the standard for detecting chromosome
abnormalities in miscarriages samples. It is one of the whole genome
techniques. However, it may be hampered by maternal contamination,
culture failure or overgrowth and poor quality of the chromosomal prep-
arations. No fetal karyotype result is available in about 20% of the samples
tested [25]. Another disadvantage is the limited resolution (b3–5 Mb).
For a full overview of advantages and disadvantages of all techniques
used for detecting chromosome abnormalities, see Table 1. Chromosomal
Table 2
Cytogenetic ﬁndings among reported series of spontaneous miscarriage samples by conventional karyotyping (percentages in parentheses).
Study Total number
of samples studied
Failuresa Successful karyotypes Trisomy Polyploidy Monosomy X Structural chromosome
abnormalities
Othersb
Normal Abnormal
n n n (%) n (%) n (% of abn) n (% of abn) n (% of abn) n (% of abn) n (% of abn)
Lomax 2000 301 48 (16) 98 (39) 155 (61) 111 (72)c 25 (16) 12 (8) 7 (5) 0
Tabet 2001 21 0 10 (48) 11 (52) 6 (55) 1 (9) 1 (9) 3 (27) 0
Jobanputra 2002 57 5 (9) 22 (42) 30 (58) 17 (57) 6 (20) 2 (7) 0 5 (17)
Schaeffer 2004 41 0 25 (61) 16 (39) 13 (81) 1 (6) 1 (6) 1 (6) 0
Sullivan 2004 150 17 (11) 77 (58) 56 (42) 53 (63) 12 (21) 5 (9) 3 (5) 0
Hu 2006 38 7 (18) 15 (48) 16 (52) 12 (75) 2 (13) 2 (13) 0 0
Bruno 2006 78 11 (14) 38 (57) 29 (43) 17 (59) 3 (10) 2 (7) 7 (24) 0
Diego-alvarez 2007 221 119 (54) 62 (61) 40 (39) 24 (60) 5 (13) 6 (15) 1 (3) 4 (10)
Menten 2009 100 28 (28) 55 (76) 16 (23) 9 (53) 3 (18) 2 (12) 2 (12) 0
Robberecht 2009 103 26 (25) 55 (71) 22 (29) 10 (45) 5 (23) 6 (27) 1(5) 0
Zhang 2009 115 23 (20) 37 (40) 55 (60) 36 (65) 8 (15) 5 (9) 2 (4) 4 (7)
Doria 2009 232 59 (25) 107 (62) 66 (38)d 36 (55) 13 (20) 6 (9) 5 (8) 15 (23)
Shearer 2011 5555 2194 (39)e 1627 (48) 1734 (52)f 1074 (62) 278 (16) 260 (15) 135 (8) 89 (5)
Total 7012 2537 2228 2246 1418 362 310 167 117
Prevalence 21% 55% 45% 63% 17% 11% 6% 6%
(95% CI)g (13–30) (48–61) (38–52) (59–68) (15–19) (8–14) (4–8) (2–11)
a Failures included: No fetal tissue found and failure of technique.
b Others included: mosaicism, double, triple and quadruple trisomies, autosomal monosomy and one trisomy plus a balanced translocation.
c Described as aneuploidy.
d 66 cases with an abnormal karyotype; 75 chromosome abnormalities are found.
e Failures included 1366 unidentiﬁed tissue samples.
f Subtypes of chromosome abnormalities could only be calculated in 1836 abnormal miscarriage samples including 102 unidentiﬁed tissue samples.
g Pooled estimates of the proportions with 95% CI were calculated using a random-effects meta-analyses in STATA 11.2.
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hybridization (array-CGH), ﬂuorescence in situ hybridization (FISH),
multiplex ligation-dependent probe ampliﬁcation (MLPA) and quantita-
tive ﬂuorescent polymerase chain reaction (QF-PCR) are molecular tech-
niques that are often said to deal with (a part of) the limitations of
conventional karyotyping. Thesemolecular techniques can be subdivided
in whole genome techniques (chromosomal-CGH and array-CGH) and
chromosome speciﬁc techniques (FISH, MLPA and QF-PCR). However, a
good comparison of these techniques has not been done so far.
2.4.1. Chromosomal comparative genomic hybridization (CGH)
Chromosomal-CGH is a technique that allows for the detection
of losses and gains in DNA copy number across the entire genome.
Resolution is limited to metaphase chromosomes (5–10 Mb pairs).
Four studies evaluated the accuracy of chromosomal-CGH compared
to conventional karyotyping. In total 369 sporadic miscarriage sam-
ples were investigated both by karyotyping as chromosomal-CGH
(Table 5) [17,18,21,34]. It is important to realize that the studies
differ in resolution of the tests used, sample sizes and diverge
with regard to proportion of chromosome abnormalities detected byTable 3
Cytogenetic ﬁndings among reported series of recurrent miscarriage samples by conventio
Study Total number of
samples studied
Failuresa Successful karyotypes Trisomy
Normal Abnormal
n n (%) n (%) n (%) n (% of abn
Stern 1996 94 0 40 (43) 54 (57) 45 (83)c
Ogasawara 2000 458 224 (49) 114 (49) 120 (51) 63 (52)
Carp 2001 167 42 (25) 89 (71) 36 (29) 24 (67)
Stephenson 2002 472 58 (12)d 225 (54) 195 (46) 122 (63)
Sullivan 2004 135 13 (10) 91 (75) 31 (25) 21 (68)
Halder 2006 33 18 (55) 12 (80) 3 (20) 1 (33)
Total 1359 355 571 439 276
Prevalence 25% 61% 39% 65%
(95% CI)e (9–41) (50–71) (29–50) (54–76)
a Failures included: No fetal tissue found an failure of technique.
b Others included: mosaicism, double, triple and quadruple trisomies and autosomal mo
c Described as aneuploidy.
d In 58 samples cytogenetic analysis was unsuccessful, however there were six sets of di
e Pooled estimates of the proportions with 95% CI were calculated using a random-effectchromosomal-CGH (range of chromosome abnormalities 33–67%).
Compared to chromosomal-CGH (52% (95% CI: 36–68), karyotyping
detected a comparable amount of chromosome abnormalities (60%
(95% CI: 49–72) in sporadic miscarriage samples. Also chromosomal-
CGH missed a comparable amount of the abnormalities (6% (95%
CI: 0–12)) compared to karyotyping which missed 2% (95% CI: 1–4) of
the abnormalities.
Only one study compared chromosomal-CGH with karyotyping in
miscarriage samples from women with recurrent miscarriage [35]. In
this relatively small study chromosomal-CGH detected more abnor-
malities than conventional karyotyping (13 versus 5 abnormalities).
Chromosomal-CGH and conventional karyotyping were performed
on 12 samples, karyotyping detected ﬁve chromosome abnormalities
while chromosomal-CGH detected six abnormalities. The other seven
abnormalities were detected among 15 samples in which karyotyping
failed. These abnormalities were unbalanced translocations. At ﬁrst
sight this seems logical, however the number of samples tested is
simply too small to draw ﬁrm conclusions.
The use of chromosomal-CGH alone in clinical cytogenetics has
severe limitations. Ploidy status or balanced chromosomeabnormalitiesnal karyotyping (percentages in parentheses).
Polyploidy Monosomy X Structural chromosome
abnormalities
Othersb
) n (% of abn) n (% of abn) n (% of abn) n (% of abn)
9 (17) Not documented Not documented Not documented
18 (15) 5 (4) 0 34 (28)
5 (14) 5 (14) 2 (6) 0
37 (19) 18 (9) 8 (4) 10 (5)
6 (19) 3 (10) 1 (3) 0
1 (33) 0 0 1 (33)
76 31 11 45
17% 8% 3% 13%
(14–21) (4–12) (0–6) (0–26)
nosomy.
amnotic twins therefore there were 420 samples with a successful karyotyping.
s meta-analyses in STATA 11.2.
Table 4
Additional submicroscopic ﬁndings in miscarriage samples detected by array-CGH and not detected with conventional karyotyping among reported series of women with sporadic
miscarriage (percentages in parentheses).
Study Total number of
samples studied
n
Submicroscopic
abnormalities
n (%)
Type of submicroscopic abnormalities Study description
Schaeffer 2004 41 3/41 (7) Duplication of the 10q telomere region; deletion at 9p21;
duplication of the 15q telomere region
41 samples were analyzed by both array-CGH
and conventional karyotyping
Benkhalifa 2005 26 2/26 (8) Duplication of 1p-terminal; deletion at 22q13a 26 samples were analyzed by array-CGH that
failed to grow in culture
Shimokawa
2006
20 1/20 (5) Deletion at 3p26.2–p26.3 corresponding to clone
RP11-30m15
20 samples with a normal karyotype were
analyzed by array-CGH
Menten 2009 100 3/100 (3) Duplication of (13)(q32.1qter) combined with deletion
at (20)(pterp12.1); deletion at (7)(q36qter); deletion at
(X)(q28qter)
100 samples were analyzed by both array-CGH
in combination with FCM and conventional
karyotyping
Robberecht 2009 103 1/91 (1) Deletion of ﬁve clones (787.5 kb) at the steroid sulfatase
locus
103 samples were analyzed by both array-CGH
and conventional karyotyping
Zhang 2009 58 5/58 (9) Deletion at 9p21.1; duplication of 2p12; duplication of
9q22.33; duplication of 19p11.2; duplication of 18p11.31
58 samples with normal karyotypes and
non-poliploidy after culture failure were
analyzed by array-CGH
Rajcan-Separovic
2010
14 5/14b (36) Duplication of 10p15.3; duplication of 17p13.1; deletion
at 1q25.3; duplication of Xq28; duplication of 13q32.1;
deletion at 7q14.3
14 euploid miscarriage samples were
analyzed by array-CGH
Total 362 20
Prevalence Proportion
(95% CI)c 5% (1–8)
CGH: comparative genomic hybridization.
FCM: ﬂow cytometry.
a In one patient a monosomy 21 and a small ampliﬁcation of 2 BACs at the X-chromosome were detected; the monosomy 21 being the main cause of miscarriage.
b 6 chromosome abnormalities in 5 embryos.
c Pooled estimates of the proportions with 95% CI were calculated using a random-effects meta-analyses in STATA 11.2.
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performing FISH or ﬂow cytometry (FCM) additionally. One study com-
bined chromosomal-CGH and FCM in a total of 253 spontaneousmiscar-
riages samples [17]. The combination of the two techniques revealed
12/253 additional chromosome abnormalities compared to convention-
al karyotyping alone, because of culture failure. These results suggest
that chromosomal-CGH supplementedwith FCMcan overcome the lim-
itations of chromosomal-CGH alone and karyotyping.
Karyotyping may suffer from culture failure. One study performed
chromosomal-CGH on 57 samples after culture failure by using
karyotyping [36]. More than half of the miscarriage samples (65%, 37/
57) showed chromosomal abnormalities by using chromosomal-CGH.
Chromosomal-CGH can be used as an additional technique when
karyotyping cannot be performed.
2.4.2. Array‐comparative genomic hybridization (array-CGH)
Array-CGH screens the whole genome for submicroscopic chromo-
somal changes. So, more abnormalities can be detected by array-CGH
compared to chromosomal CGH. Four studies evaluated the accuracy of
array-CGH compared to conventional karyotyping on, in total, 264
sporadic miscarriage samples (Table 6) [8,9,20,37]. The studies differ in
resolution of the tests used, sample sizes and diverge with regard to pro-
portion of chromosome abnormalities detected by array-CGH (range of
chromosome abnormalities 27–41%). Whereas array-CGH was used
for detecting chromosomal aberrations, less abnormalities remained
undetected compared to conventional karyotyping (array-CGH missed
2% (95% CI: 0–5) compared to 10% (95% CI: 6–14) by karyotyping).This
could be explained by the fact that karyotyping has a higher failure rate
(18% (95% CI: 7–30)) compared to array-CGH (5% (95% CI: 0–10)). Also,
array-CGH detected submicroscopic abnormalities which remained
undetectable for karyotyping (20 submicroscopic abnormalities of the
362 samples tested, 5%).
Overall, conventional karyotyping detected an equal number of
chromosome abnormalities (30% (95% CI: 23–37) when compared to
array-CGH (31% (95% CI: 14–38) in sporadic miscarriage samples.
Evidence on the value of array-CGH in recurrent miscarriage is
limited. Array-CGH can be used as an additional technique when
conventional karyotyping fails. Table 7 shows that after culture failurearray-CGH detects additional abnormalities. These abnormalities
accounted for respectively 17 and 58% of the miscarriages samples in
which karyotyping was unsuccessful, and were mostly trisomies and
monosomies [30,33]. If only karyotyping was used these test results
would not be possible.
As mentioned above (Section 2.4.1 Chromosomal comparative
genomic hybridization), the use of array- CGH alone in clinical cyto-
genetics has severe limitations. To overcome these limitations one
study combined array-CGH and FCM [8]. Compared to conventional
karyotyping alone, the combination of array-CGH and FCM showed
10/100 additional chromosome abnormalities. To overcome the limi-
tations of array-CGH alone, this technique can be supplemented with
FCM. This combination also can overcome the limitations of conven-
tional karyotyping.
2.5. Accuracy of the chromosome region speciﬁc techniques
2.5.1. Fluorescence in situ hybridization (FISH)
FISH is a mapping technique, which uses ﬂuorescently labeled
DNA probes to detect gains or losses of speciﬁc segments of DNA. It
can be used as an additional technique for accurate cytogenetic eval-
uation of spontaneous miscarriages materials or to conﬁrm the cyto-
genetic results, because FISH uses probes with speciﬁc genomic
segments. Table 8 shows that FISH is a reliable technique to detect ab-
normalities where karyotyping failed [25,38–41]. However, the probe
kits used, differed per study as shown in Table 8. One study included
the largest number of miscarriage samples (n=5555) and performed
FISH successfully in 727/762 (95%) samples after culture failure [25].
So, in 95% a result could be obtained. We excluded unidentiﬁed tissue
samples because of the reported high risk of maternal contamination.
Another study used FISH with Y chromosome probe (DYZ3:
p11.1–q11.1 region) in 45 samples with an 46,XX karyotype to detect
maternal contamination [42]. In two cases the Y-probe proved positive
thus making maternal contamination plausible. Maternal contamina-
tion may result in false negative outcomes.
Only one study reporting on 57 sporadic miscarriage samples used
FISH as additional technique to conventional karyotyping [19]. In this
study, FISH identiﬁed chromosome abnormalities in four out of ﬁve
Table 5
Studies reporting on a comparison of CGH versus conventional karyotyping in sporadic miscarriage samples (percentages in parentheses).
Study Total number of
samples studied
Failures
using CGHa
Failures using
karyotypinga
CGH chromosome
abnormalities
Karyotyping chromosome
abnormalities
Abnormalities
missed by CGH/
conﬁrmed by
karyotypingb
Abnormalities missed
by karyotyping/
conﬁrmed by CGHc
n n (%) n (%) n (%) n (%) n n
Lomax 2000d 301 48 (16) 48 (16) 161/253 (64) 155/253 (61) 0 6
Bell 2001e 9 0 0 6/9 (67) 9/9 (100) 3 0
Tabet 2001f 21 0 2 (8) 7/21 (33) 11/21 (52) 3 0
Hu 2006 38 0 7 (18) 17/38 (45) 16/31 (45) 0 1
Total 369 48 57 191 191 6 7
Proportion
(95% CI)g
12% (1–22) 16% (12–19) 52% (36–68) 60% (49–72) 6% (0–12) 2% (1–4)
CGH: comparative genomic hybridization.
FCM: ﬂow cytometry.
aFailures included: No fetal tissue found an failure of technique.
bAbnormalities missed by CGH: aneuploidy, polyploidy and structural chromosome abnormalities.
cAbnormalities missed by karyotyping: aneuploidy, polyploidy and structural chromosome abnormalities.
dCGH+FCM analysis.
eCGH performed in 9 samples with conﬁrmed chromosome abnormalities by karyotyping.
fSamples included ﬁrst, second and third trimester miscarriages.
gPooled estimates of the proportions with 95% CI were calculated using a random-effects meta-analyses in STATA 11.2.
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proved to be false negative and showed a chromosome abnormality
using FISH. This can be explained by maternal contamination. Other-
wise, FISH missed four abnormalities because the probe was not
designed to detect the speciﬁc trisomy.
2.5.2. Multiplex ligation-dependent probe ampliﬁcation (MLPA)
MLPA is a multiplex PCR-based technique detecting abnormal
copy numbers of up to 50 different genomic DNA sequences, using
only small amounts of DNA (20–200 ng) [39]. Only few studies report
on MLPA as a technique to detect chromosome abnormalities in spo-
radic or recurrent miscarriages samples. Only three studies compared
MLPA versus karyotyping in sporadic miscarriages samples; Table 9
[10,22,37]. However, these studies used different MLPA kits, so the
data cannot be pooled. All chromosome abnormalities missed
by karyotyping were due to culture failure. The drawback of using
MLPA is that polyploidy cannot be detected. One MLPA study success-
ful investigated 74 samples [22]. Of the 74 samples, MLPA missed two
triploid chromosome abnormalities. One study compared MLPA
versus karyotyping in recurrent miscarriages samples [43]. MLPA tech-
nique missed more frequently a diagnosis (36/284 (13%)) compared
to conventional karyotyping (8/284 (3%)). Otherwise, conventional
karyotyping failed in 50/284 (18%) of the cases, due to culture failure
(41 samples) and putrefaction of the tissue samples (9 samples).
While MLPA showed no result in 4/284 (1%) of the samples, due toTable 6
Studies reporting on a comparison of array-CGH versus conventional karyotyping in sporad
Study Total number
of samples
studied
Failures using
array-CGHa
Failures using
karyotypinga
array-CG
chromos
abnorm
n n (%) n (%) n (%)
Schaeffer 2004 41 0 0 17/41 (4
Menten 2009d,e 100 2 (2) 28 (28) 26/98 (2
Robberecht 2009 103 12 (12) 26 (25) 26/91 (2
Desphande 2010 20 0 0 8/20 (4
Total 264 14 54 77
Proportion (95% CI)f 5% (0–10) 18% (7–30) 31% (1
CGH: comparative genomic hybridization.
a Failures included: No fetal tissue found an failure of technique.
b Abnormalities missed by array-CGH: aneuploidy, structural chromosome abnormalities
c Abnormalities missed by karyotyping: aneuploidy, polyploidy, mosaicism and submicro
d CGH+FCM analysis.
e Samples included ﬁrst, second and third trimester miscarriages.
f Pooled estimates of the proportions with 95% CI were calculated using a random-effectpoor tissue quality (3 samples) and a low mass of DNA (1 sample). So,
in case of culture failure, MLPAmay be an alternative, but polyploidy re-
mains undetected. If MLPA with subtelomeric probes was used when
karyotyping provided no results, 37% of the cases showed chromosome
abnormalities [44].
2.5.3. Quantitative ﬂuorescent polymerase chain reaction (QF-PCR)
QF-PCR is a method in which DNA polymorphic markers on chro-
mosomes are used to determine the presence of different alleles.
The assay based on the use of informative polymorphic small tandem
repeat (STR) markers (microsatellites) is used for prenatal and post-
natal diagnosis of aneuploidies of chromosomes 13, 18, 21, X and Y.
In 2005, this technique was ﬁrst used to evaluate the value of short
tandem repeats (microsatellites) of numerical chromosomal anoma-
lies in 160 sporadic miscarriage samples with markers on nine differ-
ent chromosomes (chromosomes 2, 7, 13, 15, 16, 18, 21, 22 and X)
compared to karyotyping. Discrepancies between the two techniques
occurred in eight out of 89 cases (9%). QF-PCR identiﬁed ﬁve chromo-
somally male miscarriage samples in which karyotyping showed a
female karyotype, caused by maternal overgrowth. In two of these
samples a trisomy 13 was identiﬁed by QF-PCR. In three cases an
aneuploidy (the type of aneuploidywas notmentioned)was diagnosed
by karyotyping, while QF-PCR showed a normal female pattern [23].
Another study used QF-PCR to detect chromosome abnormalities
in 61 sporadic miscarriages samples and 48 controls. They usedic miscarriage samples (percentages in parentheses).
H
ome
alities
Karyotyping
chromosome
abnormalities
Abnormalities missed by
array-CGH/conﬁrmed
by karyotypingb
Abnormalities missed by
karyotyping/conﬁrmed
by array-CGHc
n (%) n n
1) 16/41 (39) 0 4
7) 17/72 (24) 1 10
9) 22/77 (29) 4 10
0) 8/20 (40) 0 0
63 5 24
4–38) 30% (23–37) 2% (0–5) 10% (6–14)
.
scopic abnormalities.
s meta-analyses in STATA 11.2.
Table 7
Studies reporting on chromosome testing by using array-CGH alone or after failed conventional karyotyping in sporadic miscarriage samples (percentages in parentheses).
Study Total number of samples studied Array-CGH chromosome abnormalities Explanation
n n (%)
Benkhalifa 2005 26 15/26 (58) Array-CGH performed in 26 samples after culture failurea
Warren 2009b 30 5/30 (17) Karyotyping not performed in 26 samples, and normal in 4 samplesc
CGH: comparative genomic hybridization.
a The detected abnormalities were triploidy, trisomy/monosomy 1, 8, 13, 14, 16, 18, 21, 22 and X, one loss on 22q13, one gain 1p terminal and one ampliﬁcation on the X chro-
mosome was detected.
b Samples: fetal loss between 10 and 20 weeks of gestation.
c The detected abnormalities were trisomy 21, monosomy X, triploidy and a triploidy with an trisomy 13.
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normalities (chromosomes 13, 14, 15, 16, 18, 21, 22 and sex chromo-
somes). Twenty-two (22/61; 36%) samples were diagnosed with a
numerical abnormality. Only two cases showed another outcome than
the result of karyotyping; both karyotyping as well as QF-PCR technique
missed one abnormality [45]. QF-PCR missed a 46XY/46XX karyotype
conﬁrmed by karyotyping. Another sample karyotyping showed 46 XX,
while QF-PCR showed irregular peaks.
One study used PCR-based microsatellite genotyping for the iden-
tiﬁcation of trisomy or polyploidy in those cases of culture failure
or maternal cell contamination [7]. PCR-based genotyping identiﬁed
2/23 (9%) cases with triploidy.
Since the number of chromosomes tested for in this technique is
limited, the question whether QF-PCR is a reliable technique on its
own, leads to discussion. A great disadvantage is that this technique
works with markers for speciﬁc chromosomes and does not screen
the whole genome. So the success rate largely depends on the chro-
mosome markers used. Few studies reported about the use of
QF-PCR, so more research is required to determine whether this tech-
nique can be used on its own as a diagnostic tool to detect chromo-
some abnormalities in miscarriage samples. An advantage above
karyotyping is that it is fast and relatively cheap. Furthermore, com-
pared to MLPA, it can detect polyploidies.
3. Discussion
Testing miscarriage samples for the purpose of determining
the genetic contribution causing the loss is of undisputable value. A
miscarriage can be regarded as a rescue mechanism, to prevent
an implanted but abnormal pregnancy from further growth [46].
Although it has been frequently mentioned that the prevalence of
chromosome abnormalities in miscarriage samples is higher than
50% and the ﬁnding of submicroscopic chromosome abnormalities
contributes to an even higher percentage of chromosome abnormali-
ties, this could not be conﬁrmed after carefully reviewing existing
literature [7–9]. The prevalence of chromosome abnormalities
whether tested by the gold standard, chromosome region speciﬁcTable 8
Studies reporting on outcomes of FISH in sporadic miscarriage samples (percentages in par
Study Chromosome probes used Total number of
samples studied
Samples
abnorma
n n (%)
Lebedev 2004 1, 5, 13–16, 18, 19, 21, 22, X, Y 60a 32/60
Lescoat 2005 13, 16, 18, 21, X, Y 202 83/196
Vorsanova 2005b 1, 9, 13, 14, 15, 16, 18, 21, 22, X, Y 148 89/148
Jobanputra 2011 13, 15, 16, 18, 21, 22, X, Y 324 108/324
Shearer 2011 13, 16, 18, 21, 22, X, Y 762 181/727
FISH: ﬂuorescence in situ hybridization.
a 146 samples were collected, FISH analysis was performed in 60 samples.
b Failures are not reported.techniques and whole genome techniques in sporadic and recurrent
miscarriage samples on average never exceeded half of the samples
tested. A chromosomal cause for the loss therefore only exists in
maximum 50% of all miscarriages.
Opinions differ as to the usefulness of karyotyping of miscarriage
samples for routine clinical practice. There is no clear relevance for
clinical decision-making, but a genetic test result may provide infor-
mation for the woman or couple in question [47]. Guidelines on the
topic of recurrent miscarriage vary with regard to their advices. The
European Society of Obstetrics and Gynaecology (ESHRE) advises
genetic evaluation of miscarriage samples only within the setting
of scientiﬁc studies [48]. The Royal College of Obstetricians and
Gynaecologists (RCOG) recommends fetal karyotyping for chromo-
some abnormalities whereas in contrast the Dutch Society of
Obstetrics and Gynaecology (NVOG) recommends no fetal cytogenet-
ic analysis [49,50].
This review provides an overview of what is currently known
about (submicroscopic) genetic abnormalities in sporadic and recur-
rent miscarriage samples by the use of the whole genome techniques
(karyotyping, chromosomal-CGH and array-CGH) and chromosome
region speciﬁc techniques (FISH, MLPA and QF-PCR). Cytogenetic ab-
normalities in miscarriages are re-evaluated by providing an over-
view of recent literature since 2000. The prevalence of chromosome
abnormalities in women facing a single sporadic miscarriage proved
to be 45% (95% CI: 38–52) in 7012 samples collected. The prevalence
of chromosome abnormalities in women undergoing a subsequent
miscarriage after preceding RM was 39% (95% CI: 29–50) in 1359
samples collected. The overall pooled prevalence of submicroscopic
abnormalities additionally found next to conventional karyotyping
in sporadic miscarriage samples was 5%. However, the clinical rele-
vance of submicroscopic abnormalities, whether it is a causal factor,
is not clear in most reported cases.
At present, more chromosome abnormalities are found by using
the gold standard (conventional karyotyping) than by the use of
FISH or MLPA. However, data about these techniques are limited
and the detection rate of FISH or MLPA strongly depends on the num-
ber and type of chromosomes tested as karyotyping provides a wholeentheses).
with chromosome
lities detected by FISH
Explanation
(53) FISH after culture failure
(42) FISH after culture failure
(60) Only FISH applied
(33) FISH in 171 samples with a normal karyotype and in 153
samples after culture failure or contamination
(25) FISH after culture failure, unidentiﬁed tissue excluded
Table 9
Studies reporting on a comparison of MLPA versus conventional karyotyping in sporadic miscarriage samples (percentages in parentheses).
Study MLPA kit Total number
of samples
studied
Samples with
chromosome
abnormalities detected
by MLPA
Samples with chromosome
abnormalities detected by
karyotyping
Samples with abnormalities
missed by MLPA/detected
by karyotyping
Samples with abnormalities
missed by karyotyping/
detected by MLPA
n n (%) n (%) n n
Bruno 2006 Subtelomeric probe kits 78 28/74 (38) 29/67 (43) 2 1
Desphande 2010 Subtelomeric probe kits 20 4/20 (20) 8/20 (40) 2 0
Carvalho 2010a,b Aneuploidy
(chromosomes 13,
18, 21, X and Y)
489 38/489 (8) 98/328 (30) 60 13
MLPA: Multiplex ligation-dependent probe ampliﬁcation.
a 38 out of the 489 samples were intra-uterine fetal deaths, the other samples were miscarriage samples.
b In 161 samples only MLPA results were available.
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no cell culture is needed, as 20% of the cell cultures fails [25]. QF-PCR
is also a chromosome region speciﬁc technique but performed as
good as conventional karyotyping, although evidence was limited
and its result depends on the chromosome markers or probes used.
When using whole genome techniques, chromosomal-CGH detected
an equal amount of chromosome abnormalities (52% (95% CI: 36–68))
and missed a comparable amount of chromosome abnormalities (6%
(95% CI: 0–12)) compared to karyotyping (60% (95% 49–72)) and (2%
(95% CI: 1–4)). Array-CGH detected an equal number of chromosome
abnormalities (31% (95% CI: 14–38)) compared to karyotyping (30%
(95% CI: 23–37)), but missed less chromosome abnormalities (2% (95%
CI: 0–5)) compared to karyotyping (10% (95% CI: 6–14)). This can be
explained by the fact that karyotyping had a higher failure rate (18%
(95% CI: 7–30)) compared to array-CGH (5% (95% CI: 0–10)).
The molecular techniques offer the advantage of quick results and
higher resolutions. The expectations of the molecular techniques,
in particular the array-CGH, MLPA and FISH techniques are high, es-
pecially by using array-CGH, because it screens the whole genome.
Surprisingly, no more chromosome abnormalities were detected by
chromosomal-CGH, array‐CGH and FISH, and costs are higher com-
pared with the gold standard. More importantly, certain abnormali-
ties like polyploidy or balanced chromosome abnormalities remain
undetectable by chromosomal‐CGH, array-CGH and MLPA. QF-PCR
can detect polyploidy, but the detection rate of chromosome abnor-
malities is strongly correlated with the markers used.
Molecular techniques like array-CGH, FISH and MLPA may have
certain advantages apart from routine cytogenetic analysis of miscar-
riage samples for investigation of chromosomal abnormalities. FISH
and MLPA can detect only pre-selected submicroscopic abnormalities
while array-CGH can detect chromosome abnormalities in the whole
genome. These techniques enable us to detect submicroscopic chro-
mosome abnormalities which cannot be found by traditional tech-
niques. More, larger, studies should be performed to determine the
clinical relevance of the submicroscopic chromosome abnormalities.
In case of culture failure or maternal contamination, molecular
techniquesmay contribute to detect additional chromosome abnormal-
ities in these miscarriages samples in addition to standard karyotyping.
The value of knowledge on prevalence of cytogenetic abnormalities in
miscarriage samples is undisputed, but the relevance of the molecular
techniques for daily clinical practice is still a point of discussion.
4. Conclusions and recommendations
Chromosomal-CGH, array-CGH, FISH, MLPA and QF-PCR can possi-
bly play a complementary role to karyotyping, especially in case of
culture failure. By using these techniques independently, instead of
conventional karyotyping, unfortunately they show no added clinical
value. It is precisely for that reason that knowledge of submicroscopic
abnormalities and the molecular techniques needs to be improved.References
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